跳至主要内容
临床试验/JPRN-UMIN000023451
JPRN-UMIN000023451已完成未知

Efficacy and safety of greenpropolis against prostate cancer with biochemical recurrence after radical prostatectomy - Clinical trial of greenpropolis against prostate cancer

Kyoto University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Previously treated or currently be receiving hormonal therapy with the intent to treat prostate cancer (surgical castration or other hormonal manipulation, e.g. GnRH agonists or antagonists, anti-androgens or estrogens); Evidence of administration of greenpropolis or other alternative therapies within 3 months before day 1. History of allergy against honey, a coniferous tree, a poplar, Peru balsam, and salicylic acid; History of atopic dermatitis, chronic recurrent eczema, and asthma.

研究者

发起方
Kyoto University Graduate School of Medicine

相似试验

Efficacy and safety of greenpropolis against... | 临床试验